Latest Health News
INHANCE Study Named 2025 Brain Health Breakthrough of the Year
The INHANCE neuroimaging study identified the first intervention to upregulate acetylcholine production, declining with aging and dementia. BrainHQ training restored cholinergic health to levels seen in someone 10 years younger, offering hope for cognitive aging. This non-drug approach pivots brain health management like heart health.
Brazil Validates Elimination of Mother-to-Child HIV Transmission
WHO validated Brazil as the largest Americas country to eliminate mother-to-child HIV transmission just before 2025 end. No country had previously met the triple elimination goal for HIV, syphilis, and hepatitis B until Maldives in October.
This marks a record-breaking public health achievement.
Maldives Achieves Triple Elimination of Mother-to-Child Transmission
Maldives became the first nation validated by WHO for eliminating mother-to-child transmission of HIV, syphilis, and hepatitis B. Previously recognized for HIV and syphilis in 2019, it completed the trifecta with hepatitis B.
This highlights progress in global maternal health goals.
Seven Countries Introduce Malaria Vaccine in 2025
Burundi, Ethiopia, Guinea, Mali, Togo, Uganda, and Zambia rolled out the recently approved malaria vaccine, totaling 24 countries. This expands access to a critical tool against malaria.
WHO notes it as a key advancement in prevention.
Lenacapavir Approved as Twice-Yearly HIV Prevention Injection
Lenacapavir, injected biannually to prevent HIV, gained U.S. approval and support via 4 million doses from U.S. and Global Fund. The Trump administration honored the Biden-era commitment.
It represents a major step in HIV prevention arsenal.
Fatal Rabies Case from Dog Bite in Pakistan's Sindh
A human fatality from dog bite rabies reported in Sindh, Pakistan on December 31. ProMED highlights ongoing risks in the region.
This underscores persistent challenges in rabies control.
Hantavirus Fatality in Argentina's Santa Fe Province
A hantavirus case resulted in death in Santa Fe, Argentina, reported December 31. Part of ongoing Americas outbreaks.
Vigilance needed for rodent-borne risks.
FDA Approves First Blood Test for Alzheimer’s Diagnosis
In May, FDA authorized a blood test for Alzheimer’s in adults 50+ with cognitive decline, showing 92% accuracy in trials. This aids early diagnosis.
A significant non-invasive tool.
World’s First CRISPR Patient Discharged After Gene Therapy
KJ Muldoon, treated for severe carbamoyl phosphate synthetase 1 deficiency, discharged in June after CRISPR therapy at CHOP. First successful bespoke gene-editing case.
Marks milestone in personalized medicine.
Two Billion nOPV2 Polio Vaccines Deployed Globally
Over two billion doses of novel oral polio vaccine type 2 (nOPV2) delivered worldwide by December 31. Critical for outbreak response.
Enhances polio eradication efforts.
VIZZ Eyedrops Approved for Age-Related Farsightedness
LENZ Therapeutics' VIZZ drops improve vision by three+ eye chart lines in 30 minutes, targeting presbyopia. Chosen as Popular Science's 2025 Health winner.
Potential end to reading glasses for many.
US Commits $480M to Ivory Coast Health Programs
U.S.-Ivory Coast deal funds HIV, malaria, maternal/child health, and global health security. Latest in international health investments.
Aims to strengthen regional capacities.